Back
Apellis Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$22.81
Seasonality Move:
5.14%
7 Day Trial
ALL ACCESS PASS
$
7
Apellis Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Apellis Pharmaceuticals, Inc. has on average historically risen by 19.8% based on the past 8 years of stock performance.
-
Apellis Pharmaceuticals, Inc. has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Apellis Pharmaceuticals, Inc. Stock Undervalued?The current Apellis Pharmaceuticals, Inc. [APLS] share price is $22.80. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Apellis Pharmaceuticals, Inc. has on average historically risen by 19.8% based on the past 8 years of stock performance.
Apellis Pharmaceuticals, Inc. Stock Rating
Sell
48
Apellis Pharmaceuticals, Inc. (APLS)
is a Sell
Is Apellis Pharmaceuticals, Inc. overpriced?
-
Apellis Pharmaceuticals, Inc. has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Apellis Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
30.48
52-Week Low:
16.10
Prediction Charts
Market Cap:
2.9B
Price in USD:
22.80
Volume:
2M
Beta:
0.87
Technical Analysis
SMA50:
23.43
SMA100:
23.17
SMA200:
22.22
52-Wk Change:
-19.69%
Stock Predictions
-
Is Apellis Pharmaceuticals, Inc. stock public?Yes, Apellis Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Apellis Pharmaceuticals, Inc. stock quote today?The Apellis Pharmaceuticals, Inc. stock price is 22.80 USD today.
-
How to buy Apellis Pharmaceuticals, Inc. stock online?You can buy Apellis Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-30 | 22.96 | 22.58 | 23.42 | 21.80 |
| Feb-2 | 22.04 | 22.83 | 23.39 | 21.59 |
| Feb-3 | 22.50 | 23.32 | 23.93 | 22.50 |
| Feb-4 | 23.32 | 23.15 | 23.44 | 22.69 |
| Feb-5 | 23.31 | 22.56 | 24.10 | 22.29 |
| Feb-6 | 22.68 | 23.49 | 23.58 | 22.57 |
| Feb-9 | 22.94 | 22.83 | 23.69 | 22.70 |
| Feb-10 | 23.12 | 22.58 | 23.18 | 22.51 |
| Feb-11 | 22.46 | 22.31 | 22.50 | 21.71 |
| Feb-12 | 22.23 | 22.05 | 22.38 | 21.72 |
| Feb-13 | 22.05 | 21.70 | 22.55 | 21.54 |
| Feb-17 | 21.68 | 21.57 | 21.93 | 21.30 |
| Feb-18 | 21.59 | 22.20 | 22.41 | 21.59 |
| Feb-19 | 22.05 | 22.80 | 22.81 | 21.64 |
Apellis Pharmaceuticals, Inc. Earnings
Apellis Pharmaceuticals, Inc. Earnings Report: Per Share Apellis Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals, Inc. Forecast Revenue Growth
Apellis Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $1.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.56 per share, and an increase next year of $0.89 per share.
* Apellis Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.